These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18633951)

  • 1. 8-pCPT-2'-O-Me-cAMP-AM: an improved Epac-selective cAMP analogue.
    Vliem MJ; Ponsioen B; Schwede F; Pannekoek WJ; Riedl J; Kooistra MR; Jalink K; Genieser HG; Bos JL; Rehmann H
    Chembiochem; 2008 Sep; 9(13):2052-4. PubMed ID: 18633951
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced Rap1 activation and insulin secretagogue properties of an acetoxymethyl ester of an Epac-selective cyclic AMP analog in rat INS-1 cells: studies with 8-pCPT-2'-O-Me-cAMP-AM.
    Chepurny OG; Leech CA; Kelley GG; Dzhura I; Dzhura E; Li X; Rindler MJ; Schwede F; Genieser HG; Holz GG
    J Biol Chem; 2009 Apr; 284(16):10728-36. PubMed ID: 19244230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cAMP signalling protects proximal tubular epithelial cells from cisplatin-induced apoptosis via activation of Epac.
    Qin Y; Stokman G; Yan K; Ramaiahgari S; Verbeek F; de Graauw M; van de Water B; Price LS
    Br J Pharmacol; 2012 Feb; 165(4b):1137-50. PubMed ID: 21745194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of sulfonylurea action by an EPAC-selective cAMP analog in INS-1 cells: comparison of tolbutamide and gliclazide and a potential role for EPAC activation of a 2-APB-sensitive Ca2+ influx.
    Jarrard RE; Wang Y; Salyer AE; Pratt EP; Soderling IM; Guerra ML; Lange AM; Broderick HJ; Hockerman GH
    Mol Pharmacol; 2013 Jan; 83(1):191-205. PubMed ID: 23071106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B.
    Rehmann H; Arias-Palomo E; Hadders MA; Schwede F; Llorca O; Bos JL
    Nature; 2008 Sep; 455(7209):124-7. PubMed ID: 18660803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epac inhibits apoptosis of human leukocytes.
    Grandoch M; Bujok V; Fleckenstein D; Schmidt M; Fischer JW; Weber AA
    J Leukoc Biol; 2009 Oct; 86(4):847-9. PubMed ID: 19564576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension.
    Christensen AE; Selheim F; de Rooij J; Dremier S; Schwede F; Dao KK; Martinez A; Maenhaut C; Bos JL; Genieser HG; Døskeland SO
    J Biol Chem; 2003 Sep; 278(37):35394-402. PubMed ID: 12819211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural dynamics in the activation of Epac.
    Harper SM; Wienk H; Wechselberger RW; Bos JL; Boelens R; Rehmann H
    J Biol Chem; 2008 Mar; 283(10):6501-8. PubMed ID: 18167352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.
    Islam D; Zhang N; Wang P; Li H; Brubaker PL; Gaisano HY; Wang Q; Jin T
    Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E174-81. PubMed ID: 18854429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epac: a new cAMP target and new avenues in cAMP research.
    Bos JL
    Nat Rev Mol Cell Biol; 2003 Sep; 4(9):733-8. PubMed ID: 14506476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cAMP/Epac1/Rap1 pathway in pancreatic carcinoma.
    Lorenz R; Aleksic T; Wagner M; Adler G; Weber CK
    Pancreas; 2008 Jul; 37(1):102-3. PubMed ID: 18580452
    [No Abstract]   [Full Text] [Related]  

  • 12. Gonadotropin-stimulated epidermal growth factor receptor expression in human ovarian surface epithelial cells: involvement of cyclic AMP-dependent exchange protein activated by cAMP pathway.
    Choi JH; Chen CL; Poon SL; Wang HS; Leung PC
    Endocr Relat Cancer; 2009 Mar; 16(1):179-88. PubMed ID: 19022848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epac and the cardiovascular system.
    Schmidt M; Sand C; Jakobs KH; Michel MC; Weernink PA
    Curr Opin Pharmacol; 2007 Apr; 7(2):193-200. PubMed ID: 17276729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epac activates the small G proteins Rap1 and Rab3A to achieve exocytosis.
    Branham MT; Bustos MA; De Blas GA; Rehmann H; Zarelli VE; Treviño CL; Darszon A; Mayorga LS; Tomes CN
    J Biol Chem; 2009 Sep; 284(37):24825-39. PubMed ID: 19546222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epac-Rap signaling reduces oxidative stress in the tubular epithelium.
    Stokman G; Qin Y; Booij TH; Ramaiahgari S; Lacombe M; Dolman ME; van Dorenmalen KM; Teske GJ; Florquin S; Schwede F; van de Water B; Kok RJ; Price LS
    J Am Soc Nephrol; 2014 Jul; 25(7):1474-85. PubMed ID: 24511123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epac-Rap signaling reduces cellular stress and ischemia-induced kidney failure.
    Stokman G; Qin Y; Genieser HG; Schwede F; de Heer E; Bos JL; Bajema IM; van de Water B; Price LS
    J Am Soc Nephrol; 2011 May; 22(5):859-72. PubMed ID: 21493776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro.
    Lissitzky JC; Parriaux D; Ristorcelli E; Vérine A; Lombardo D; Verrando P
    Cancer Res; 2009 Feb; 69(3):802-9. PubMed ID: 19176384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Rac 1 and cAMP in endothelial barrier stabilization and thrombin-induced barrier breakdown.
    Baumer Y; Spindler V; Werthmann RC; Bünemann M; Waschke J
    J Cell Physiol; 2009 Sep; 220(3):716-26. PubMed ID: 19472214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of Selective Enzyme Inhibition through Uncompetitive Regulation of an Allosteric Agonist.
    Boulton S; Selvaratnam R; Blondeau JP; Lezoualc'h F; Melacini G
    J Am Chem Soc; 2018 Aug; 140(30):9624-9637. PubMed ID: 30016089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial factors mediate aldosterone release via PKA-independent pathways.
    Ansurudeen I; Willenberg HS; Kopprasch S; Krug AW; Ehrhart-Bornstein M; Bornstein SR
    Mol Cell Endocrinol; 2009 Mar; 300(1-2):66-70. PubMed ID: 19073232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.